Sermorelin Peptide 5mg

Description

Sermorelin 5mg – Research-Grade Peptide for GHRH and Endocrine Signaling Studies

Delivery: Laboratory Research-Grade, 5mg Vial Supplied at 99%+ purity.

Other sizes. The same compound is also supplied as a 10mg vial.

Sermorelin 5mg is a synthetic, research-grade peptide designed for advanced laboratory studies focused on growth hormone-releasing hormone (GHRH) analogs, endocrine signaling pathways, and peptide biology research. It is widely used in scientific investigations exploring pituitary signaling, peptide interactions, and molecular mechanisms in controlled laboratory environments.

This product is strictly for research purposes and is not approved for human consumption, clinical, or veterinary use.

What Is Sermorelin?

Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). In laboratory settings, Sermorelin is used to investigate:

• Peptide–receptor interactions and signaling mechanisms
• Pituitary hormone signaling models in vitro or ex vivo
• Peptide stability, structure, and analytical characterization
• Endocrine pathway studies under controlled experimental conditions
• Laboratory-based peptide biology and mechanistic research

All applications are strictly non-clinical and intended for scientific study only.

Research Applications of Sermorelin 5mg

Sermorelin 5mg is suitable for laboratory research, including:

• GHRH Signaling Studies – Mechanistic investigation of peptide interactions with pituitary receptors
• Endocrine Pathway Research – Exploration of peptide effects on molecular signaling in controlled experiments
• Peptide Pharmacology & Analytical Biology – Laboratory studies involving synthetic peptide activity
• Experimental Models of Hormone Signaling – Research using in vitro or ex vivo models of endocrine pathways
• Controlled Laboratory Peptide Research – Peptide studies for mechanistic and receptor biology investigations

All uses are limited to scientific research purposes.

Product Specifications

• Peptide: Sermorelin
• Concentration: 5mg per vial
• Grade: Research-Grade
• Storage: Maintain according to standard peptide laboratory protocols

The 5mg format allows flexible experimental design for early-stage, dose-response, or small-scale studies.

Purity & Quality Assurance

ExoLabz peptides are produced under strict quality control standards. ExoLabz products undergo independent third-party testing to verify identity, purity, and content. Results are published on this site. Researchers may submit the peptide for verification. If specifications are not met, ExoLabz provides a refund and testing reimbursement, ensuring full research integrity.

Important Legal Disclaimer

For Research Purposes Only
Sermorelin 5mg is intended strictly for scientific research and laboratory investigation. It is not approved by the FDA, Health Canada, or any other regulatory authority. This product is not for human consumption, clinical, or veterinary use. By purchasing, you agree to use it exclusively for lawful laboratory research.

Compound identity and specification

Identity data for Sermorelin, published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.

Analytical note — Sermorelin. At 29 residues this is long enough that deletion and truncation by-products from incomplete coupling sit close to the target mass. A mass difference of one residue against a 3,358 g/mol parent is a small relative shift, so mass resolution matters more here than on a short peptide.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

• Lance VA, et al. Biochem Biophys Res Commun. 1984;119(1):265-272. Structure-activity study measuring GH-releasing potency of GRF(1-29)-amide and substituted analogs in cultured pituitary cells and rodent assays. Source · PMID 6231028
• Clark RG, Robinson ICAF Nature. 1985;314(6008):281-283. In normal and GHRF-deficient rats, measured growth rate and pituitary GH content under pulsatile versus continuous infusion at matched daily dose. Source · PMID 2858818
• Frohman LA, et al. J Clin Invest. 1989;83(5):1533-1540. In human plasma in vitro, measured enzymatic cleavage sites and degradation kinetics, identifying DPP-IV N-terminal cleavage as the inactivating step. Source · PMID 2565342

Literature notes: This molecule is indexed in the primary literature as GRF(1-29)NH2 or GHRH(1-29)NH2 rather than under the name sermorelin.

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Related Research Compounds

Browse more compounds in GHS, or view the full research peptide catalogue.

• TESAMORELIN 10mg
• AOD-9604 5mg
• CJC-1295 (NO DAC) 5mg
• IPAMORELIN 10mg

Background on the compound: sermorelin, GHRH(1-29) and the reference analog — where DPP-4 cleaves it, why the C-terminal amide matters, and how it compares with tesamorelin and CJC-1295.